| scholarly article | Q13442814 |
| P50 | author | Zhihang Chen | Q57273751 |
| P2093 | author name string | Marie-France Penet | |
| Zaver M Bhujwalla | |||
| Cong Li | |||
| Paul T Winnard | |||
| Dmitri Artemov | |||
| Tomoyo Takagi | |||
| Flonné Wildes | |||
| P2860 | cites work | Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment | Q24317541 |
| The structure of Escherichia coli cytosine deaminase | Q27637502 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Side-effects of a systemic injection of linear polyethylenimine-DNA complexes | Q28192320 | ||
| 5-Fluorouracil: mechanisms of action and clinical strategies | Q28201937 | ||
| Structures of O-linked oligosaccharides present in the proteoglycans secreted by human mammary epithelial cells | Q70134324 | ||
| Isolation and characterization of proteoglycans secreted by normal and malignant human mammary epithelial cells | Q70280900 | ||
| Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers | Q28217662 | ||
| Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells | Q28259789 | ||
| Mechanisms of gene silencing by double-stranded RNA | Q28282560 | ||
| A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine | Q29616154 | ||
| Studies of human tumors by MRS: a review | Q30833628 | ||
| The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies | Q30973716 | ||
| Tumour phospholipid metabolism | Q33179622 | ||
| In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. | Q33184714 | ||
| Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer | Q33372268 | ||
| Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer | Q33881902 | ||
| Applications of molecular MRI and optical imaging in cancer | Q33986159 | ||
| Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy | Q34135239 | ||
| Strategies for enzyme/prodrug cancer therapy. | Q34436759 | ||
| Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA. | Q34640040 | ||
| RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy | Q34759878 | ||
| Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions | Q34790978 | ||
| Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase | Q35693935 | ||
| From bench to bedside for gene-directed enzyme prodrug therapy of cancer | Q36061340 | ||
| Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization | Q36178042 | ||
| siRNA-based approaches in cancer therapy | Q36373107 | ||
| Novel gene-directed enzyme prodrug therapies against prostate cancer | Q36543076 | ||
| Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. | Q36607242 | ||
| Choline metabolism in cancer: implications for diagnosis and therapy | Q36670926 | ||
| Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. | Q36900208 | ||
| Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy | Q37160825 | ||
| Transport of molecules in the tumor interstitium: a review | Q39768023 | ||
| Conjugation of poly-L-lysine to bacterial cytosine deaminase improves the efficacy of enzyme/prodrug cancer therapy | Q39976413 | ||
| Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer | Q39981076 | ||
| In vivo imaging of siRNA delivery and silencing in tumors | Q40166593 | ||
| Multimodal image-guided enzyme/prodrug cancer therapy | Q40206021 | ||
| RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation | Q40344986 | ||
| Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action. | Q40513977 | ||
| Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells | Q40979828 | ||
| Production of sulfated proteoglycans by human breast cancer cell lines: binding to fibroblast growth factor-2. | Q41120686 | ||
| Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system | Q42812609 | ||
| Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells. | Q42833424 | ||
| Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols | Q44891522 | ||
| Image-guided enzyme/prodrug cancer therapy | Q46788931 | ||
| Dissemination of Information on Potentially Fatal Adverse Drug Reactions for Cancer Drugs From 2000 to 2002: First Results From the Research on Adverse Drug Events and Reports Project | Q60148401 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6707-6716 | |
| P577 | publication date | 2010-10-19 | |
| P1433 | published in | ACS Nano | Q2819067 |
| P1476 | title | Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy | |
| P478 | volume | 4 |
| Q39161466 | A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect. |
| Q47106820 | Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation. |
| Q35537301 | Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein |
| Q35112040 | Choline metabolism in malignant transformation |
| Q37636194 | Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy |
| Q38657755 | Genetically encoded iron-associated proteins as MRI reporters for molecular and cellular imaging |
| Q35312455 | High-field small animal magnetic resonance oncology studies. |
| Q38710046 | Imaging-guided delivery of RNAi for anticancer treatment |
| Q37974175 | In vivo imaging of the systemic delivery of small interfering RNA. |
| Q36949372 | MR - eyes for cancer: looking within an impenetrable disease |
| Q30354223 | Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches |
| Q38982546 | Magnetic Resonance Imaging and Spectroscopy in Cancer Theranostic Imaging |
| Q36910668 | Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy |
| Q35064453 | Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade |
| Q30367515 | Molecular imaging of the tumor microenvironment for precision medicine and theranostics. |
| Q38112726 | Multimodality imaging of RNA interference |
| Q38383478 | Nanomedicine for gene therapy. |
| Q91928770 | Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives |
| Q38814327 | Oligonucleotide-based theranostic nanoparticles in cancer therapy |
| Q38808957 | PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer. |
| Q33791366 | PSMA-targeted theranostic nanoplex for prostate cancer therapy. |
| Q40262447 | Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage |
| Q28255877 | Progress toward in vivo use of siRNAs-II |
| Q35618915 | Recent advances in nonviral vectors for gene delivery |
| Q35625854 | Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. |
| Q39084885 | Targeting Phospholipid Metabolism in Cancer |
| Q88502315 | Theranostics and metabolotheranostics for precision medicine in oncology |
| Q49207200 | Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer |
| Q38191832 | Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy |
Search more.